Edgewise Therapeutics (EWTX) Earnings Date & Reports
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
EWTX is expected to report earnings to -53 cents per share on November 05
Q3'26
Est.
$-0.54
Q2'26
Missed
by $0.06
Q1'26
Beat
by $0.03
Q4'25
Missed
by $0.03
Q3'25
Beat
by $0.01
The last earnings report on August 06 showed earnings per share of -52 cents, missing the estimate of -46 cents. With 739.05K shares outstanding, the current market capitalization sits at 4.80B.